Destination Therapy Strategies of Advanced Heart Failure in Elderly Non-Heart Transplant Candidates

Heart transplantation (HT) is the gold standard therapy for advanced heart failure (ADHF), and LVADs as destination therapy are an option in non-HT candidates. Most patients with ADHF never receive HT or an LVAD, so alternative strategies are needed. Intermittent levosimendan can reduce HF hospitali...

Descripción completa

Detalles Bibliográficos
Autores: Dobarro, David|||0000-0003-0716-254X, Raposeiras-Roubin, Sergio|||0000-0002-6462-4715, Almenar Bonet, Luis|||0000-0002-7710-361X, Solé González, Eduard|||0000-0002-5727-9925, Padilla-Lopez, Mireia|||0000-0002-4374-3870, Díez-López, Carles|||0000-0002-3734-4777, Castrodeza, Javier|||0000-0002-4779-6849, García-Cosío, María Dolores, Cobo-Marcos, M.|||0000-0002-9026-061X, Tobar, Javier, Codina, Pau|||0000-0002-2469-5711, Lopez-Fernandez, Silvia|||0000-0002-2461-8492, Pastor, Francisco|||0000-0002-9818-2409, Rangel Sousa, Diego|||0000-0003-2435-0155, Barge-Caballero, Eduardo, Díaz-Molina, Beatriz|||0000-0002-7773-8121, Barrio-Rodriguez, Alfredo, Burgos-Palacios, Virginia, Alvarez-Garcia, Jesus|||0000-0002-2015-6446, González-Fernández, Óscar|||0000-0003-3069-6101, Grau-Sepulveda, Andrés, García Pinilla, José Manuel|||0000-0001-5999-5741, Ruiz Bustillo, Sonia|||0000-0002-6074-914X, Mendez-Fernández, Ana B., Vaqueriza-Cubillo, David|||0000-0002-8207-7604, Sagasti-Aboitiz, Igor, Rodriguez-Santamarta, Miguel, Lozano-Bahamonde, Ainara, Abecia, Ana, Gómez-Otero, Inés, Marzoa, Raquel, González-Babarro, Eva, Gómez-Bueno, Manuel|||0000-0002-9764-7518, González-Costello, José|||0000-0002-7437-3630
Tipo de recurso: artículo
Fecha de publicación:2024
País:España
Institución:Universitat Autònoma de Barcelona
Repositorio:Dipòsit Digital de Documents de la UAB
Idioma:inglés
OAI Identifier:oai:ddd.uab.cat:310164
Acceso en línea:https://ddd.uab.cat/record/310164
https://dx.doi.org/urn:doi:10.3390/life14121570
Access Level:acceso abierto
Palabra clave:LVAD
Advanced heart failure
Inotropes
id ES_df44c855115d07be19e2b6587469d67f
oai_identifier_str oai:ddd.uab.cat:310164
network_acronym_str ES
network_name_str España
repository_id_str
spelling Destination Therapy Strategies of Advanced Heart Failure in Elderly Non-Heart Transplant CandidatesA Propensity Matching Analysis from the LEVO-D and REGALAD RegistriesDobarro, David|||0000-0003-0716-254XRaposeiras-Roubin, Sergio|||0000-0002-6462-4715Almenar Bonet, Luis|||0000-0002-7710-361XSolé González, Eduard|||0000-0002-5727-9925Padilla-Lopez, Mireia|||0000-0002-4374-3870Díez-López, Carles|||0000-0002-3734-4777Castrodeza, Javier|||0000-0002-4779-6849García-Cosío, María DoloresCobo-Marcos, M.|||0000-0002-9026-061XTobar, JavierCodina, Pau|||0000-0002-2469-5711Lopez-Fernandez, Silvia|||0000-0002-2461-8492Pastor, Francisco|||0000-0002-9818-2409Rangel Sousa, Diego|||0000-0003-2435-0155Barge-Caballero, EduardoDíaz-Molina, Beatriz|||0000-0002-7773-8121Barrio-Rodriguez, AlfredoBurgos-Palacios, VirginiaAlvarez-Garcia, Jesus|||0000-0002-2015-6446González-Fernández, Óscar|||0000-0003-3069-6101Grau-Sepulveda, AndrésGarcía Pinilla, José Manuel|||0000-0001-5999-5741Ruiz Bustillo, Sonia|||0000-0002-6074-914XMendez-Fernández, Ana B.Vaqueriza-Cubillo, David|||0000-0002-8207-7604Sagasti-Aboitiz, IgorRodriguez-Santamarta, MiguelLozano-Bahamonde, AinaraAbecia, AnaGómez-Otero, InésMarzoa, RaquelGonzález-Babarro, EvaGómez-Bueno, Manuel|||0000-0002-9764-7518González-Costello, José|||0000-0002-7437-3630LVADAdvanced heart failureInotropesHeart transplantation (HT) is the gold standard therapy for advanced heart failure (ADHF), and LVADs as destination therapy are an option in non-HT candidates. Most patients with ADHF never receive HT or an LVAD, so alternative strategies are needed. Intermittent levosimendan can reduce HF hospitalizations in ADHF patients in the short term. It is uncertain whether the results of the comparison of inotropes with older-generation LVADs would have the same outcomes in the current era of ADHF patients treated with levosimendan, who are less sick but older. In this paper, we compare the use of two therapeutic strategies for end-stage HF in patients who are not candidates for HT: repetitive intermittent levosimendan vs. LVAD as destination therapy. To do so, we compare two multicenter cohorts of real-life patients from Spain: the LEVO-D registry and the REGALAD registry. In total, 715 patients coming from the two registries were found: 403 from LEVO-D and 312 from REGALAD. Non-adjusted median survival was shorter for LEVO-D patients, with the benefit for the LVADs seen only after the first year of therapy. The survival advantage for the LVAD cohort was also true after analysis of the matched cohort but, as in the non-matched analysis, the survival benefit was mainly shown after one year of follow-up. We conclude that in elderly ADHF non-HT candidates, LVAD therapy offers significantly better long-term outcomes when compared to intermittent levosimendan; thus, it should be considered in carefully selected candidates. On the other hand, in poor LVAD candidates or highly comorbid patients, intermittent inotropic support with levosimendan could be a reasonable alternative to LVAD, as 1-year outcomes are similar.Universitat Autònoma de Barcelona 22024-01-0120242024-01-01Articlehttp://purl.org/coar/resource_type/c_6501VoRhttp://purl.org/coar/version/c_970fb48d4fbd8a85info:eu-repo/semantics/articleapplication/pdfhttps://ddd.uab.cat/record/310164https://dx.doi.org/urn:doi:10.3390/life14121570reponame:Dipòsit Digital de Documents de la UABinstname:Universitat Autònoma de BarcelonaInglésengopen accesshttp://purl.org/coar/access_right/c_abf2Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, la comunicació pública de l'obra i la creació d'obres derivades, fins i tot amb finalitats comercials, sempre i quan es reconegui l'autoria de l'obra original.https://creativecommons.org/licenses/by/4.0/info:eu-repo/semantics/openAccessoai:ddd.uab.cat:3101642026-06-06T12:50:31Z
dc.title.none.fl_str_mv Destination Therapy Strategies of Advanced Heart Failure in Elderly Non-Heart Transplant Candidates
A Propensity Matching Analysis from the LEVO-D and REGALAD Registries
title Destination Therapy Strategies of Advanced Heart Failure in Elderly Non-Heart Transplant Candidates
spellingShingle Destination Therapy Strategies of Advanced Heart Failure in Elderly Non-Heart Transplant Candidates
Dobarro, David|||0000-0003-0716-254X
LVAD
Advanced heart failure
Inotropes
title_short Destination Therapy Strategies of Advanced Heart Failure in Elderly Non-Heart Transplant Candidates
title_full Destination Therapy Strategies of Advanced Heart Failure in Elderly Non-Heart Transplant Candidates
title_fullStr Destination Therapy Strategies of Advanced Heart Failure in Elderly Non-Heart Transplant Candidates
title_full_unstemmed Destination Therapy Strategies of Advanced Heart Failure in Elderly Non-Heart Transplant Candidates
title_sort Destination Therapy Strategies of Advanced Heart Failure in Elderly Non-Heart Transplant Candidates
dc.creator.none.fl_str_mv Dobarro, David|||0000-0003-0716-254X
Raposeiras-Roubin, Sergio|||0000-0002-6462-4715
Almenar Bonet, Luis|||0000-0002-7710-361X
Solé González, Eduard|||0000-0002-5727-9925
Padilla-Lopez, Mireia|||0000-0002-4374-3870
Díez-López, Carles|||0000-0002-3734-4777
Castrodeza, Javier|||0000-0002-4779-6849
García-Cosío, María Dolores
Cobo-Marcos, M.|||0000-0002-9026-061X
Tobar, Javier
Codina, Pau|||0000-0002-2469-5711
Lopez-Fernandez, Silvia|||0000-0002-2461-8492
Pastor, Francisco|||0000-0002-9818-2409
Rangel Sousa, Diego|||0000-0003-2435-0155
Barge-Caballero, Eduardo
Díaz-Molina, Beatriz|||0000-0002-7773-8121
Barrio-Rodriguez, Alfredo
Burgos-Palacios, Virginia
Alvarez-Garcia, Jesus|||0000-0002-2015-6446
González-Fernández, Óscar|||0000-0003-3069-6101
Grau-Sepulveda, Andrés
García Pinilla, José Manuel|||0000-0001-5999-5741
Ruiz Bustillo, Sonia|||0000-0002-6074-914X
Mendez-Fernández, Ana B.
Vaqueriza-Cubillo, David|||0000-0002-8207-7604
Sagasti-Aboitiz, Igor
Rodriguez-Santamarta, Miguel
Lozano-Bahamonde, Ainara
Abecia, Ana
Gómez-Otero, Inés
Marzoa, Raquel
González-Babarro, Eva
Gómez-Bueno, Manuel|||0000-0002-9764-7518
González-Costello, José|||0000-0002-7437-3630
author Dobarro, David|||0000-0003-0716-254X
author_facet Dobarro, David|||0000-0003-0716-254X
Raposeiras-Roubin, Sergio|||0000-0002-6462-4715
Almenar Bonet, Luis|||0000-0002-7710-361X
Solé González, Eduard|||0000-0002-5727-9925
Padilla-Lopez, Mireia|||0000-0002-4374-3870
Díez-López, Carles|||0000-0002-3734-4777
Castrodeza, Javier|||0000-0002-4779-6849
García-Cosío, María Dolores
Cobo-Marcos, M.|||0000-0002-9026-061X
Tobar, Javier
Codina, Pau|||0000-0002-2469-5711
Lopez-Fernandez, Silvia|||0000-0002-2461-8492
Pastor, Francisco|||0000-0002-9818-2409
Rangel Sousa, Diego|||0000-0003-2435-0155
Barge-Caballero, Eduardo
Díaz-Molina, Beatriz|||0000-0002-7773-8121
Barrio-Rodriguez, Alfredo
Burgos-Palacios, Virginia
Alvarez-Garcia, Jesus|||0000-0002-2015-6446
González-Fernández, Óscar|||0000-0003-3069-6101
Grau-Sepulveda, Andrés
García Pinilla, José Manuel|||0000-0001-5999-5741
Ruiz Bustillo, Sonia|||0000-0002-6074-914X
Mendez-Fernández, Ana B.
Vaqueriza-Cubillo, David|||0000-0002-8207-7604
Sagasti-Aboitiz, Igor
Rodriguez-Santamarta, Miguel
Lozano-Bahamonde, Ainara
Abecia, Ana
Gómez-Otero, Inés
Marzoa, Raquel
González-Babarro, Eva
Gómez-Bueno, Manuel|||0000-0002-9764-7518
González-Costello, José|||0000-0002-7437-3630
author_role author
author2 Raposeiras-Roubin, Sergio|||0000-0002-6462-4715
Almenar Bonet, Luis|||0000-0002-7710-361X
Solé González, Eduard|||0000-0002-5727-9925
Padilla-Lopez, Mireia|||0000-0002-4374-3870
Díez-López, Carles|||0000-0002-3734-4777
Castrodeza, Javier|||0000-0002-4779-6849
García-Cosío, María Dolores
Cobo-Marcos, M.|||0000-0002-9026-061X
Tobar, Javier
Codina, Pau|||0000-0002-2469-5711
Lopez-Fernandez, Silvia|||0000-0002-2461-8492
Pastor, Francisco|||0000-0002-9818-2409
Rangel Sousa, Diego|||0000-0003-2435-0155
Barge-Caballero, Eduardo
Díaz-Molina, Beatriz|||0000-0002-7773-8121
Barrio-Rodriguez, Alfredo
Burgos-Palacios, Virginia
Alvarez-Garcia, Jesus|||0000-0002-2015-6446
González-Fernández, Óscar|||0000-0003-3069-6101
Grau-Sepulveda, Andrés
García Pinilla, José Manuel|||0000-0001-5999-5741
Ruiz Bustillo, Sonia|||0000-0002-6074-914X
Mendez-Fernández, Ana B.
Vaqueriza-Cubillo, David|||0000-0002-8207-7604
Sagasti-Aboitiz, Igor
Rodriguez-Santamarta, Miguel
Lozano-Bahamonde, Ainara
Abecia, Ana
Gómez-Otero, Inés
Marzoa, Raquel
González-Babarro, Eva
Gómez-Bueno, Manuel|||0000-0002-9764-7518
González-Costello, José|||0000-0002-7437-3630
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Universitat Autònoma de Barcelona
dc.subject.none.fl_str_mv LVAD
Advanced heart failure
Inotropes
topic LVAD
Advanced heart failure
Inotropes
description Heart transplantation (HT) is the gold standard therapy for advanced heart failure (ADHF), and LVADs as destination therapy are an option in non-HT candidates. Most patients with ADHF never receive HT or an LVAD, so alternative strategies are needed. Intermittent levosimendan can reduce HF hospitalizations in ADHF patients in the short term. It is uncertain whether the results of the comparison of inotropes with older-generation LVADs would have the same outcomes in the current era of ADHF patients treated with levosimendan, who are less sick but older. In this paper, we compare the use of two therapeutic strategies for end-stage HF in patients who are not candidates for HT: repetitive intermittent levosimendan vs. LVAD as destination therapy. To do so, we compare two multicenter cohorts of real-life patients from Spain: the LEVO-D registry and the REGALAD registry. In total, 715 patients coming from the two registries were found: 403 from LEVO-D and 312 from REGALAD. Non-adjusted median survival was shorter for LEVO-D patients, with the benefit for the LVADs seen only after the first year of therapy. The survival advantage for the LVAD cohort was also true after analysis of the matched cohort but, as in the non-matched analysis, the survival benefit was mainly shown after one year of follow-up. We conclude that in elderly ADHF non-HT candidates, LVAD therapy offers significantly better long-term outcomes when compared to intermittent levosimendan; thus, it should be considered in carefully selected candidates. On the other hand, in poor LVAD candidates or highly comorbid patients, intermittent inotropic support with levosimendan could be a reasonable alternative to LVAD, as 1-year outcomes are similar.
publishDate 2024
dc.date.none.fl_str_mv 2
2024-01-01
2024
2024-01-01
dc.type.none.fl_str_mv Article
http://purl.org/coar/resource_type/c_6501
VoR
http://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.openaire.fl_str_mv info:eu-repo/semantics/article
format article
dc.identifier.none.fl_str_mv https://ddd.uab.cat/record/310164
https://dx.doi.org/urn:doi:10.3390/life14121570
url https://ddd.uab.cat/record/310164
https://dx.doi.org/urn:doi:10.3390/life14121570
dc.language.none.fl_str_mv Inglés
eng
language_invalid_str_mv Inglés
language eng
dc.rights.none.fl_str_mv open access
http://purl.org/coar/access_right/c_abf2
https://creativecommons.org/licenses/by/4.0/
dc.rights.openaire.fl_str_mv info:eu-repo/semantics/openAccess
rights_invalid_str_mv open access
http://purl.org/coar/access_right/c_abf2
https://creativecommons.org/licenses/by/4.0/
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.source.none.fl_str_mv reponame:Dipòsit Digital de Documents de la UAB
instname:Universitat Autònoma de Barcelona
instname_str Universitat Autònoma de Barcelona
reponame_str Dipòsit Digital de Documents de la UAB
collection Dipòsit Digital de Documents de la UAB
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869422049071464448
score 15,812429